GOHIBIC

This brand name is authorized in Lithuania, United States

Active ingredients

The drug GOHIBIC contains one active pharmaceutical ingredient (API):

1 Vilobelimab UNII F5T0RF9ZJA - VILOBELIMAB

Vilobelimab is a chimeric human/mouse monoclonal IgG4 antibody that is a specific inhibitor of the soluble human complement component C5a. Read about Vilobelimab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GOHIBIC Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AJ10		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AJ Complement inhibitors
Discover more medicines within L04AJ10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1102332
Country: US	FDA, National Drug Code	Identifier(s): 83000-110